NVAX — Novavax, Inc. stock price, charts and financials

QT45Novavax, Inc.

Novavax, Inc. (NASDAQ: NVAX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
7.84
-0.11-1.38%
OverviewShort InterestFilings
NVAXQT45Novavax, Inc.·NASDAQ
7.84-1.38%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 2026S-8Registration of employee benefit securities
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 06, 202610-QQuarterly report
May 06, 20268-KCurrent report
Apr 30, 2026SC 13GBeneficial ownership statement (passive)
Apr 28, 20264Statement of changes in beneficial ownership
Apr 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 27, 2026DEFA14AAdditional proxy soliciting materials
Apr 27, 2026ARSAnnual report to shareholders
Apr 27, 2026DEF 14ADefinitive proxy statement
Apr 16, 20264Statement of changes in beneficial ownership
Apr 16, 20263Initial statement of beneficial ownership
Apr 08, 2026SC 13D/ABeneficial ownership statement (active, amended)
#1 / 25 of 418
Page
▼
/ 17